about
Assessment and classification of patients with myocardial injury and infarction in clinical practiceNew Guidelines for the Management of Chest Pain: Lessons From a Recent Audit in Tauranga, New Zealand.Rapid Rule-Out of Acute Myocardial Injury Using a Single High-Sensitivity Cardiac Troponin I Measurement.Steroid-responsive polyradiculopathy in association with focal segmental glomerulosclerosis.Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome.A single blood test to rule out acute coronary syndrome.Potential costs of B-type natriuretic peptide for the identification of people with heart failure in primary care in Scotland - a pilot study.High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome.Fulminant hepatic failure in autoimmune polyendocrine syndrome type-1.Refining the Diagnosis of Type 2 Myocardial InfarctionIncidence and outcomes of unstable angina compared with non-ST-elevation myocardial infarctionContemporary point of care cardiac troponin testing in suspected acute coronary syndromeConvalescent troponin and cardiovascular death following acute coronary syndromeClinical determinants of plasma cardiac biomarkers in patients with stable chest painNovel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndromeHigh-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action
P50
Q28078265-6A359060-EBF8-4E35-A41E-5221D58A42C9Q37711493-A9E3114B-14A2-4497-9337-466E3C91FB1FQ38385152-17763922-48CD-4F1C-86C6-E59F449709F9Q40840691-7B4C8E1D-F246-4BE0-A1A4-D2824DD1659EQ47414008-59FC0ACF-1125-4561-9521-678783A9A010Q48111795-708D9403-8393-4D99-A37C-DB32E69057DCQ48229386-24E946C8-EB6F-46B1-BFC0-18D72E026BF8Q49600199-179772E5-E48C-4B51-B0E2-3B4F96623488Q53423562-FBB1F24D-B9B2-4438-AB4F-37E00E60274AQ64446878-6C4F9EDA-3027-4A08-9D9B-0EDE3C4B60DAQ90281724-F08A01D6-08AC-4BEB-BEDC-F81A532ADED7Q91408837-AFAEB35D-900E-4C68-9573-32B0C29DDE2FQ92133292-E164BAB2-4547-4E97-9645-583B14D5D333Q92465933-798E6D76-D7B3-4402-87F1-F95D71737332Q93159889-97255EC3-4909-4184-A6A9-9A215ADE814FQ93268219-F7BB441F-08AC-4AB2-A99C-F6BE4FBDA4E0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrew R Chapman
@ast
Andrew R Chapman
@en
Andrew R Chapman
@es
Andrew R Chapman
@nl
type
label
Andrew R Chapman
@ast
Andrew R Chapman
@en
Andrew R Chapman
@es
Andrew R Chapman
@nl
prefLabel
Andrew R Chapman
@ast
Andrew R Chapman
@en
Andrew R Chapman
@es
Andrew R Chapman
@nl
P106
P31
P496
0000-0003-1926-5925